Throughout 2017, the editorial team has had the pleasure and honor of interviewing inspiring and gifted individuals in the industry. Given that the end of the year is traditionally a time to reflect on the last 12 months, and also to look ahead and make new resolutions for the year to come, I thought it would be fitting to seek words of wisdom from our 2017 “Sitting Down With...” interviews. “This industry is changing rapidly and we need to keep pace by fostering an industry culture of lifelong skills acquisition.” Dominic Carolan, January 2017
“I’d like to see more collaboration between pharma companies – not only in terms of developing a given cell therapy, but in the development of combination treatment strategies.” Catherine Bollard, February 2017 “I get intellectual stimulation from working with very bright people, and it’s scientifically rewarding to look at the new techniques that are coming through and to try and introduce them to the labs that I work with.” Fiona Greer, March 2017 “I hope that as our understanding of disease improves we will see new therapies – not just new, advanced therapies, but also older drugs being repositioned and repurposed for different diseases.” Daniel O’Connor, April 2017 “Taking the risk of stepping outside your area of expertise exposes you to other aspects of the industry and provides a wider perspective, necessary for reaching full career development potential.” Ian Muir, May 2017
“We need to make it easier for patients to participate in clinical trials. Many patients still do not even know anything about how to get involved with a clinical trial.” Elisa Cascade, June 2017 “There tends to be something of a trickle down model in the pharma and biotech industry, where poorer communities are an afterthought of the target population. I would love to see more companies working to develop therapies with vulnerable communities in mind from the very beginning.” Steve Davis, July 2017 “The generics industry seems to go through highs and lows, and I think it’s currently going through a bit of a low, but I keep telling people that now is the time to be resilient and to have confidence in your values.” Abhijit Mukherjee, September 2017 “It’s important for everyone participating in the pharma and biotech industry to have some understanding of the critical role that outsourcing providers play today.” Cornell Stamoran, October 2017 “We are living in a world where science is increasingly devalued and the role of expertise is often dismissed. But so much of what we do is underpinned by science – whether we recognize it or not.” Margaret Hamburg, November 2017
Stephanie Sutton
Editor
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
